Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Magnetic resonance angiography at 0.3 T using MS-325.

K M Lahti1, R B Lauffer, T Chan

  • 1EPIX Medical, 71 Roger Street, Cambridge, MA 02142, USA.

Magma (New York, N.Y.)
|June 8, 2001
PubMed
Summary

MS-325 significantly improved magnetic resonance angiography (MRA) image quality in rabbits compared to ProHance. This new contrast agent demonstrated enhanced vessel clarity and signal-to-noise ratios, suggesting improved diagnostic potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Association, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, Vancouver, BC, Sept. 17-21, 2013.

Canadian journal of surgery. Journal canadien de chirurgie·2025
Same author

Assessment of COVID-19 aerosol transmission in a university campus food environment using a numerical method.

Geoscience frontiers·2023
Same author

Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Society, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, London, Ont. Sept. 15-18, 2011.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

Assessing the Association Between Pre-operative Feeding and the Development of Oral Feeding Skills in Infants with Single Ventricle Heart Disease: An Analysis of the NPC-QIC Dataset.

Pediatric cardiology·2022
Same author

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers.

ESMO open·2021
Same author

[SARS-CoV-2 infections in cats, dogs, and other animal species: Findings on infection and data from Switzerland].

Schweizer Archiv fur Tierheilkunde·2021

Area of Science:

  • Radiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Magnetic Resonance Angiography (MRA) is crucial for vascular imaging.
  • Conventional contrast agents have limitations in enhancing MRA quality.
  • MS-325 is a novel contrast agent with potentially higher relaxivity.

Purpose of the Study:

  • To compare the efficacy of MS-325 versus ProHance for MRA at low field strength.
  • To evaluate the impact of MS-325 on image quality metrics like SNR and CNR.
  • To assess the in vivo performance of MS-325 in a rabbit model.

Main Methods:

  • In vivo MRA was performed in a rabbit model.
  • Images were acquired using MS-325 and ProHance contrast agents.
  • Image quality was assessed visually and quantitatively (SNR, CNR).

Related Experiment Videos

  • Comparison included pre-contrast and conventional contrast-enhanced images.

    • Main Results:

    • MS-325 demonstrated a greater enhancement effect than predicted by in vitro data.
    • Improved signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were observed with MS-325.
    • Significantly improved overall vessel clarity was noted in MS-325-enhanced images.
    • The longer vascular lifetime of MS-325 potentially matched longer scan times for better results.

    Conclusions:

    • MS-325 shows superior performance in enhancing MRA compared to ProHance.
    • The novel agent offers improved vessel clarity and image quality in low-field MRA.
    • MS-325 holds promise for advancing vascular imaging techniques.